18 studies found for: weill | Open Studies | "Gastroenteritis"
† Study has passed its completion date and status has not been verified in more than two years.
|1||Not yet recruiting||
Triage Administration of Ondansetron for Gastroenteritis in Children
|2||Not yet recruiting||
Imaging Biomarkers in Crohn's Associated Spondyloarthritis
An Efficacy and Safety Study of Infliximab in Pediatric Participants With Inflammatory Bowel Disease
A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies